Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Bio-Rad Laboratories, Inc. · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

During the six months ended June 30, 2026, there have been no material changes from the disclosures about market risk provided in our Annual Report on Form 10-K for the year ended December 31, 2025.